Muhammad Kashan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Muhammad Kashan has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Ariful Haque
Department of Orthopedic Surgery, Yan'an Hospital Affiliated to Kunming Medical University, Kunming, Yunnan, China
1 shared publication - Ayesha Irfan
Dow Medical College DUHS Karachi Pakistan
1 shared publication - Emad Uddin Sajid
Department of Medicine Dow University of Health Sciences Karachi Pakistan
1 shared publication - Erum Shahzadi Malik
Dow University of Health Sciences, Karachi, Pakistan
1 shared publication - Mabel Waqar
Department of Medicine Dow University of Health Sciences Karachi Pakistan
1 shared publication - Maria Baig
Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan
1 shared publication
Latest Publications
- Open Access
- 27 July 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (8)
Mortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023)
Background: This study evaluates national trends in heart failure (HF) and psychoactive substance abuse‐related mortality among adults aged 25 years and older in the United States (US) from 1999 to 2023, stratified by sex, age, race/ethnicity, geographic regions, and the COVID‐19 pandemic period. Methods: Data from 1999 to 2023 were extracted from the CDC WONDER database. Age‐adjusted mortality rates (AAMR) and annual percentage changes (APC) were calculated using Joinpoint regression. ICD‐10 codes I50, I50.1, I50.9 (Heart Failure), and F10‐19 (Psychoactive Substance Use) were used to identify the conditions. Results: A total of 771 739 deaths were recorded from 1999 to 2023 among individuals aged 25 and older. Most deaths occurred in medical facilities (39.24%), followed by decedents' homes (34.14%), long‐term care facilities (16.30%), hospice (6.65%), and other settings (3.67%). The AAMR increased markedly from 1.68 in 1999 to 20.7 in 2023 (AAPC of 12.09, 95% confidence interval [CI]: 10.97−14.26). A substantial increase was observed from 1999 to 2005 (APC: 38.5%, 95% CI: 29.1–55.8), followed by a slower increase until 2020 (APC: 5.68%, 95% CI: 5.02–14.8). Men showed consistently higher AAMRs than females (18.8 vs. 8.65). By age group, mortality was highest among individuals aged 65 years and older. Conclusion: Using CDC WONDER data (1999–2023), we found a sharp rise in HF mortality linked to psychoactive substance abuse, from 1.68 to 20.7 per 100 000. Mortality burden was highest among males, older adults, non‐Hispanic White individuals, and rural populations, highlighting widening demographic and geographic disparities.
- 27 July 2026
- Published by Wiley in Clinical Cardiology
- Vol. 49 (8)
Open AccessMortality Trend in Patients With Heart Failure and Psychoactive Substance Abuse in the United States—Pre‐ and Post‐COVID‐19 Pandemic Perspective (1999−2023)
Background: This study evaluates national trends in heart failure (HF) and psychoactive substance abuse‐related mortality among adults aged 25 years and older in the United States (US) from 1999 to 2023, stratified by sex, age, race/ethnicity, geographic regions, and the COVID‐19 pandemic period. Methods: Data from 1999 to 2023 were extracted from the CDC WONDER database. Age‐adjusted mortality rates (AAMR) and annual percentage changes (APC) were calculated using Joinpoint regression. ICD‐10 codes I50, I50.1, I50.9 (Heart Failure), and F10‐19 (Psychoactive Substance Use) were used to identify the conditions. Results: A total of 771 739 deaths were recorded from 1999 to 2023 among individuals aged 25 and older. Most deaths occurred in medical facilities (39.24%), followed by decedents' homes (34.14%), long‐term care facilities (16.30%), hospice (6.65%), and other settings (3.67%). The AAMR increased markedly from 1.68 in 1999 to 20.7 in 2023 (AAPC of 12.09, 95% confidence interval [CI]: 10.97−14.26). A substantial increase was observed from 1999 to 2005 (APC: 38.5%, 95% CI: 29.1–55.8), followed by a slower increase until 2020 (APC: 5.68%, 95% CI: 5.02–14.8). Men showed consistently higher AAMRs than females (18.8 vs. 8.65). By age group, mortality was highest among individuals aged 65 years and older. Conclusion: Using CDC WONDER data (1999–2023), we found a sharp rise in HF mortality linked to psychoactive substance abuse, from 1.68 to 20.7 per 100 000. Mortality burden was highest among males, older adults, non‐Hispanic White individuals, and rural populations, highlighting widening demographic and geographic disparities.
- Open Access
- 24 January 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1)
Lung cancer mortality among adults with diabetes: a retrospective analysis
Background: Both lung cancer and diabetes are the leading causes of death worldwide. These two conditions commonly coexist, especially in older patients, and result in worsening of prognosis and lower survival rates. Very limited scientific data are available about their correlation. Studying the mortality trends using data from Centers for Disease Control and Prevention Wide-Ranging Online Data of Epidemiologic Research (CDC WONDER) can help us in designing better health policies and treatment strategies. Methods: We analyzed the US mortality data from 1999 to 2023 using the CDC WONDER dataset. The ICD-10 codes were used. For lung cancer, it is C34, and for diabetes, they are E10-14. Temporal trends were analyzed by using joinpoint regression (V5.4.0) and a p value < 0.05 was considered statistically significant. Results: From 1999 to 2023, a total of 174,418 deaths were reported in the United States. Most of them occurred at home (39.6%), followed by medical facilities (33.8%). Men had mortality rates approximately twice as high as those of women. Non-Hispanic Black individuals had age adjusted mortality rates (AAMRs) approximately 2 to 3 times higher than other racial groups, peaking at 5.28 in 2005, followed by NH White, NH Other, and Hispanic or Latino, respectively. Rural areas consistently exhibited higher mortality rates. The highest AAMR was found in Kentucky (5.70), followed by West Virginia (5.24) and Oklahoma (4.94). The Southern states had a higher mortality burden. Conclusion: The rate of mortality due to lung cancer in diabetics continued to rise, with significant disparities. The research emphasizes the need for smoking cessation strategies, integrated care of diabetes and oncology, and equitable health care access to reduce the disparities. Graphical
- 24 January 2026
- Published by Springer Nature in The Egyptian Journal of Bronchology
- Vol. 20 (1)
Open AccessLung cancer mortality among adults with diabetes: a retrospective analysis
Background: Both lung cancer and diabetes are the leading causes of death worldwide. These two conditions commonly coexist, especially in older patients, and result in worsening of prognosis and lower survival rates. Very limited scientific data are available about their correlation. Studying the mortality trends using data from Centers for Disease Control and Prevention Wide-Ranging Online Data of Epidemiologic Research (CDC WONDER) can help us in designing better health policies and treatment strategies. Methods: We analyzed the US mortality data from 1999 to 2023 using the CDC WONDER dataset. The ICD-10 codes were used. For lung cancer, it is C34, and for diabetes, they are E10-14. Temporal trends were analyzed by using joinpoint regression (V5.4.0) and a p value < 0.05 was considered statistically significant. Results: From 1999 to 2023, a total of 174,418 deaths were reported in the United States. Most of them occurred at home (39.6%), followed by medical facilities (33.8%). Men had mortality rates approximately twice as high as those of women. Non-Hispanic Black individuals had age adjusted mortality rates (AAMRs) approximately 2 to 3 times higher than other racial groups, peaking at 5.28 in 2005, followed by NH White, NH Other, and Hispanic or Latino, respectively. Rural areas consistently exhibited higher mortality rates. The highest AAMR was found in Kentucky (5.70), followed by West Virginia (5.24) and Oklahoma (4.94). The Southern states had a higher mortality burden. Conclusion: The rate of mortality due to lung cancer in diabetics continued to rise, with significant disparities. The research emphasizes the need for smoking cessation strategies, integrated care of diabetes and oncology, and equitable health care access to reduce the disparities. Graphical